Clinical Trial Update: Short Term Intensified Chemo-immunotherapy in HIV-positive Patients With Burkitt Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 trial investigating short term intensified chemo-immunotherapy in HIV-positive patients with Burkitt lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burkitt Lymphoma
• HIV Infection

Snippet

Sponsor: Andres J. M. Ferreri | Conditions: HIV, Burkitt's Lymphoma | Phase 2 | Status: COMPLETED